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a  b  s  t  r  a  c  t
The  genus  Aconitum  has  strong  toxicity,  but the  acute  toxicity  of  baked  Aconitum  ﬂavum  Hand.-
Mazz.,  Ranunculaceae,  was  reduced  signiﬁcantly  on the  premise  of keeping  anti-inﬂammatory  and
anti-nociceptive  activities.  However,  the  risk associated  with  long-term  use  is unknown.  In a  sub-
chronic  toxicity  study,  rats  were  orally  administered  A.  ﬂavum  at doses  of  0.76–3.03  g/kg  for  90  days
and  further  recovered  for 14 days.  Our  results  showed  that  oral  treatment  with  A. ﬂavum  for  90 days
caused  signiﬁcant  changes  in  some  hematological  indicators  at doses  of 3.03  and  1.52  g/kg, such  as  red
blood cell,  hemoglobin,  mean  corpuscular  volume,  mean  corpuscular  hemoglobin  and  mean  corpuscular
hemoglobin  concentration.  These  results  indicated  that the  A. ﬂavum  affects  the  structure  and  function
of  red  blood  cell.  Furthermore,  signiﬁcant  changes  were  observed  in  the  white  blood  cell at  dose  of
3.03  g/kg  in male  rats,  which  conﬁrmed  tissue  damage  or toxicity.  The  liver  function  tests  exhibited  non-
signiﬁcant  alterations  in  aspertate  aminotransferase,  alanine  aminotransferase  and  avenin-like  storage
proteinsgene.  But  other  parameters,  such  as  total  protein  and  albumin  were  obviously  decreased  at  all
doses.  A.  ﬂavum  also  caused  a  signiﬁcant  decrease  in glucose,  cholesterol  and  triacylglyceride  at  all  doses.
For kidney  function,  there  were  signiﬁcant  elevations  in  urea  and  creatinine  at doses  of  3.03  and  1.52 g/kg.
The levels  of  certain  electrolytes  (Na+, K+ and  Cl−) were  signiﬁcantly  different  after  90  days  of  treatment
with  A.  ﬂavum  (3.03 and  1.52  g/kg).  Organs  were  observed  by  light  microscopy  after  hematoxylin-eosin
staining.  Hemosiderin  depositions  in  the spleen  were  observed  in  the  A.  ﬂavum  group.  These data  demon-
strated  that  the  subtoxicity  of  A.  ﬂavum  was  reduced  considerably  by baked,  but  the  subchronic  toxicity
effects  on the  liver,  kidney  and  spleen  should  not  be ignored.
© 2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  This  is an  open
he CCaccess  article  under  t
ntroduction
The genus Aconitum consists of over 300 species distributed in
sia, Europe and North America. Most of them grow in high alti-
udes in the northern hemisphere. There are 200 species in China,
uch as Aconitum kusnezofﬁi Reichb., A. carmichaelithe Debx. and A.
avum Hand.-Mazz. (Xiao, 2006). In traditional Chinese medicine,
he genus Aconitum has similar pharmacological actions and has
een commonly used for the treatment of various diseases, such as
heumatic fever, painful joints, gastroenteritis, edema, bronchial
sthma and various tumors (Singhuber et al., 2009; Qin et al.,
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2012). However, with increasing popularity, Aconitum poisoning
can occur in any part of the world because of the highly toxic
and narrow margin of safety between therapeutic and toxic doses
of these herbs. Many studies have demonstrated that the high
toxicity of Aconitum herbs is primarily attributed to diester diter-
pene alkaloids (DDA) (Chan, 2009, 2012; Singhuber et al., 2009).
Aconitine, mesaconitine, hypaconitine and other DDA are potent
cardiotoxins and neurotoxins found in all parts of the Aconitum
species, especially in the tubers and roots. Patients with Aconitum
poisoning often present with a combination of cardiovascular, neu-
rological, gastrointestinal and other signs and symptoms (Chan,
2012; Qin et al., 2012). Although patients face a huge risk, the
enthusiasm for the use of Aconitum has not diminished. Thus, it
has become a popular research topic to determine how to reduce
the toxicity and retain the therapeutic effect of the genus Aconi-
tum.
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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“Paozhi”, a traditional Chinese medicine (TCM) herbal
rocessing methods might exert much inﬂuence on the con-
ersion or transformation of plant contents and especially
econdary plant metabolites to change the toxicity or effect of
erbs. To meet the safety of clinical use, the genus Aconitum
re applied after careful processing (usually soaking, steaming,
oiling, baking and processing with Chebulae Fructus decoction)
n TCM (Wu et al., 1990; Kim et al., 2012), which could greatly
educe the toxicity of the drug by decomposing the DDA to the less
oxic monoester diterpene alkaloids (MDA). The content of DDA
ecomes relatively lower after the application of these traditional
rocessing techniques, which means that the toxicity of the drug
rops remarkably (Singhuber et al., 2009).
Aconitum ﬂavum Hand.-Mazz., Ranunculaceae, belongs to the
enus Aconitum and is widely used in western China (Shanxi,
ingxia, Gansu, Inner Mongolia, Qinghai and Tibet). It has been used
or the treatment of rheumatism, traumatic injury and toothache in
olk and clinical medicine (Wang et al., 2008). Water decoction and
owders of A. ﬂavum were used in traditional medicine for internal
nd external use.
This herb is allowed to be sold on the herbal commercial market
y the government, although it has notable toxicity in oral applica-
ion. Like other herbs of the genus Aconitum, the main chemicals
f A. ﬂavum are diester diterpene alkaloids. Thus, A. ﬂavum has
trong toxicity. Our laboratory used a variety of traditional and
odern processing methods to process A. ﬂavum and studied the
ral acute toxicity, anti-inﬂammatory and anti-nociceptive activ-
ty of differently processed products. The research showed that the
thanol extract of baked A. ﬂavum reduced its acute toxicity (LD50
2 g/kg) on the premise of maintaining anti-inﬂammatory and anti-
ociceptive activities compared to the toxicity of A. ﬂavum (LD50
.02 g/kg) in mice (Fu et al., 2013). This study laid a solid founda-
ion for the safety of A. ﬂavum applications, but the evidence of
isk from long-term use is unknown. In order to ensure the clinical
afety of baked A. ﬂavum (BA), a study of its long-term toxicity is
ecessary.
aterials and methods
reparation of ethanol root extract of baked Aconitum ﬂavum
The roots of Aconitum ﬂavum Hand.-Mazz., Ranunculaceae, were
urchased from an Herbal Medicinal Materials Company of the
ingde Pharmaceutical Co., Ltd. (Ningxia, China). The plant grows
n the Liupan mountains, Longde, Guyuan, and Ningxia, in China.
he roots were harvested from August to September. The plant
amples were authenticated by Lin Dong in the Pharmacognosy
epartment, College of Pharmacy, Ningxia Medical University, and
 voucher specimen was deposited in the same unit (Herbarium
umber: 20130924). The herb was soaked in water for 6 h, then
liced into smaller pieces and further baked at 105 ◦C for 3 h in a
acuum oven.
Baked A. ﬂavum (named BA) (3 kg) was extracted three times
ith 70% ethanol (mass ratio of solid to liquid was 1:10). The extract
as then combined and evaporated to dryness under reduced pres-
ure, then dried in a vacuum oven at 60 ◦C, which yielded 616.32 g
f residue.xperimental animals
Sprague-Dawley rats (100–130 g) were obtained from the
xperimental Animal Center of Ningxia Medical University
Ningxia, China). The rats were maintained in standardlaboratorymacognosia 26 (2016) 438–445 439
cages, in moderate humidity (50% ± 5%), at constant temperature
(22 ± 1 ◦C) in a 12-h light-dark cycle room. All animals had free
access to food and water during the experimental period. The
experimental protocol was approved by the Ethics Committee of
Ningxia Medical University (Ningxia, China, Ethics approval: 2013-
146).
Subchronic oral toxicity study
A subchronic toxicity test was performed following the reported
technique (Zhang and Du, 2012). Rats of both sexes were ran-
domly divided into four groups: control groups and three treatment
groups (n = 40; 20 males and 20 females). The LD50 of rats for a
period of 14 days was  18.2 g/kg (this value was calculated by the
Bliss method), meaning that the doses of 3.03, 1.52 and 0.76 g/kg
were selected in this subchronic toxicity study. The BA extract was
suspended in water with 0.5% (w/v) sodium carboxyl methyl cellu-
lose (Na-CMC) and administered orally on a daily basis for 90 days,
while the control group received only 0.5% sodium carboxyl methyl
cellulose (Na-CMC). Twenty rats (ten males and ten females) of each
group were sacriﬁced at the end of the 90 days. The remaining rats
in each group were continuously observed in the next 14 days and
sacriﬁced at the end. The extract was  freshly prepared with vehicle
on a daily basis.
The rats were weighed and visually observed for mortality,
behavioral patterns (salivation, coat, lethargy, and sleep), changes
in physical appearance, injury, pain and signs of illness were con-
ducted once daily during that period by one researcher. At the end
of the experiment, blood samples were collected from all animals
via abdominal aorta puncture for biochemical and hematological
analyses. The organs were excised, weighed, and examined macro-
scopically. The relative organ weight was calculated. Principal vital
organs (liver, kidney, lung, heart and spleen) were preserved in
a ﬁxation medium of 10% buffered formalin for histopathological
study.
Clinical biochemistry analysis
The blood samples were centrifuged for 15 min  to collect the
serum. Serum was  analyzed for alanine aminotransferase (ALT),
aspartate aminotransferase (AST), albumin (ALB), alkaline phos-
phatase (ALP), total protein (TP), triacylglycerol (TG), glucose (GLU),
creatinine (CREA), urea, cholesterol (CHO), sodium (Na+), potas-
sium (K+), chloride (Cl−).
Hematology analysis
The blood samples that were collected complete blood count
using the automatic hematology system to evaluate red blood cell
(RBC), white blood cell (WBC), hemoglobin (HGB), mean corpus-
cular volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), and platelet (PLT),
granulocyte (Gran), lymph, monocyte (MONO).
Histopathological study
After sacriﬁcing the rats, parts of the liver, kidney, lung, heart,
and spleen tissues were collected for histological studies. The tis-
sues were washed in normal saline and ﬁxed immediately in 10%
formalin for a period of at least 24 h, dehydrated with alcohol,
embedded in parafﬁn, cut into 4–5 m thick sections, and stained
with hematoxylin-eosin dye for photomicroscopic observation. The
microscopic features of the organs of male and female rats were
compared with the control group.
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Table 2
Relative organ weights of rats after 14 days of recovery.
Organs Control BA extracts (g/kg)
3.03 1.52 0.76
Male
Heart 0.30 ± 0.02 0.29 ± 0.03 0.29 ± 0.03 0.29 ± 0.03
Liver 2.76 ± 0.33 2.63 ± 028 2.65 ± 0.22 2.68 ± 0.26
Spleen 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02
Lungs 0.35 ± 0.04 0.35 ± 0.04 0.36 ± 0.03 0.35 ± 0.05
Kidneys 0.65 ± 0.05 0.64 ± 0.05 0.65 ± 0.05 0.64 ± 0.05
Brain 0.55 ± 0.04 0.51 ± 0.05 0.51 ± 0.04 0.53 ± 0.03
Thymus 0.08 ± 0.01 0.07 ± 002 0.07 ± 0.02 0.08 ± 0.01
Paranephros 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
Testis 0.79 ± 0.07 0.78 ± 0.07 0.79 ± 0.04 0.79 ± 0.05
Epididymis 0.28 ± 0.05 0.28 ± 0.02 0.28 ± 0.04 0.28 ± 004
Female
Heart 0.29 ± 0.03 0.29 ± 0.02 0.29 ± 0.02 0.30 ± 0.02
Liver 2.71 ± 0.24 2.76 ± 0.28 2.77 ± 0.24 2.71 ± 0.18
Spleen 0.18 ± 0.02 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02
Lungs 0.41 ± 0.05 0.40 ± 0.04 0.41 ± 0.03 0.40 ± 0.03
Kidneys 0.59 ± 0.05 0.59 ± 0.12 0.61 ± 0.08 0.59 ± 0.06
Brain 0.69 ± 0.06 0.69 ± 0.05 0.69 ± 0.04 0.69 ± 0.06
Thymus 0.10 ± 0.00 0.10 ± 0.01 0.10 ± 0.01 0.10 ± 0.01
Paranephros 0.20 ± 0.02 0.19 ± 0.07 0.19 ± 0.05 0.19 ± 0.05
Uterus 0.02 ± 0.00 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01
Ovary 0.05 ± 0.01 0.05 ± 0.00 0.05 ± 0.01 0.05 ± 0.0140 Y. Zhang et al. / Revista Brasileira
tatistical analysis
The means and standard deviations were calculated for mea-
urement data in each group, which included body weight, clinical
athological data, and relative organ weights. The homogeneity of
ariance was performed; if the variances were homogeneous, the
ingle factor analysis of variance was performed for inter-group
omparison. When the ANOVA showed signiﬁcant differences, a
unnett t test was performed. When the variances were not homo-
eneous, the Dunnett’s T3 test was performed for inter-group
omparisons. Statistical signiﬁcance was considered at p < 0.05.
esults
linical signs, necropsy ﬁndings and body weight
The animals from all treatment groups did not appear to have
ny obvious symptoms of toxicity in rats of both sexes. No deaths or
erious clinical signs were found in all groups throughout the exper-
mental period. Physical observation of the treated rats indicated
hat none of them showed signs of toxicity in their skin, fur, eyes,
ucus membrane, diarrhea, tremors, salivation, coma and behav-
oral changes. No abnormal gross ﬁndings were observed in the
ecropsies of any of the rats. Compared with the control group, all
reatment groups had nonsigniﬁcant lower weight gain from all
eeks (data not show).
elative organ weights
The relative organ weights of rats during the treatment period
nd recovery period are shown in Tables 1 and 2. The relative organ
eight of each organ recorded at necropsy in the treatment groups
id not show a signiﬁcant difference compared to the control.
ematology analysisThe effect of BA extract on hematological parameters for 90 days
treatment period) is shown in Table 3. Compared to the control
roup, MCV  and MCH  signiﬁcantly increased in both genders at
able 1
elative organ weights of rats after 90 days of treatment with BA.
Organs Control BA extracts (g/kg)
3.03 1.52 0.76
Male
Heart 0.30 ± 0.04 0.30 ± 0.05 0.28 ± 0.04 0.28 ± 0.02
Liver 2.79 ± 0.41 2.59 ± 0.30 2.58 ± 0.34 2.50 ± 0.10
Spleen 0.18 ± 0.02 0.18 ± 0.03 0.16 ± 0.03 0.17 ± 0.02
Lungs 0.36 ± 0.05 0.34 ± 0.03 0.36 ± 0.04 0.32 ± 0.04
Kidneys 0.65 ± 0.06 0.62 ± 0.04 0.63 ± 0.06 0.63 ± 0.05
Brain 0.56 ± 0.05 0.54 ± 0.05 0.51 ± 0.06 0.53 ± 0.04
Thymus 0.08 ± 0.01 0.08 ± 0.02 0.08 ± 0.03 0.08 ± 0.01
Paranephros 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
Testis 0.81 ± 0.07 0.78 ± 0.08 0.80 ± 0.09 0.78 ± 0.09
Epididymis 0.28 ± 0.05 0.28 ± 0.04 0.26 ± 0.04 0.27 ± 0.03
Female
Heart 0.28 ± 0.03 0.25 ± 0.05 0.28 ± 0.03 0.29 ± 0.04
Liver 2.74 ± 0.15 2.60 ± 0.39 2.67 ± 0.25 2.68 ± 0.19
Spleen 0.17 ± 0.02 0.14 ± 0.03 0.16 ± 0.02 0.17 ± 0.03
Lungs 0.43 ± 0.04 0.38 ± 0.13 0.40 ± 0.03 0.41 ± 0.05
Kidneys 0.60 ± 0.06 0.55 ± 0.14 0.60 ± 0.12 0.60 ± 0.07
Brain 0.72 ± 0.06 0.71 ± 0.04 0.69 ± 0.05 0.61 ± 0.11
Thymus 0.11 ± 0.01 0.11 ± 0.02 0.10 ± 0.01 0.11 ± 0.01
Paranephros 0.02 ± 0.00 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.00
Uterus 0.21 ± 0.04 0.17 ± 0.06 0.20 ± 0.06 0.21 ± 0.07
Ovary 0.05 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.05 ± 0.01
elative organ weight was calculated as (organ weight/body weight) × 100%.
he values are presented as means ± standard deviation of mean (10 rats/sex/group).Relative organ weight was calculated as (organ weight/body weight) × 100%.
The values are presented as means ± standard deviation of mean (10 rats/sex/group).
dose of 3.03 g/kg, while MCHC value signiﬁcantly increased at doses
of 1.52 and 3.03 g/kg. There were signiﬁcant increases in HGB and
RBC indices in male animals at 1.52 and 3.03 g/kg of BA groups. All
other measured hematological parameters were not signiﬁcantly
different from the control except for WBC  in respect to a signiﬁcant
increase in male rats at dose of 3.03 g/kg compared to the control
value.
At the end of the recovery period, signiﬁcant increases were
observed in the levels of MCHC and WBC  (at a dose of 3.03 g/kg) in
male animals compared to control values. MCV  only signiﬁcantly
increased at a dose of 3.03 g/kg in female rats. Additionally, no
signiﬁcant alterations in other indicators were observed (Table 4).
Clinical biochemistry analysis
Table 5 shows the results of biochemical parameters at the end
of treatment periods. Compared to the control group, the levels of
serum Na+, Cl−, TP, GLU and TG signiﬁcantly decreased but UREA
signiﬁcantly increased in the treatment groups at doses of 3.03 and
1.52 g/kg in female rats. ALB signiﬁcantly decreased at a dose of
3.03 g/kg in female rats. In addition, a statistically signiﬁcant reduc-
tion in K+ was  noted in all BA groups in female rats. For male
rats, Na+ at all doses, Cl− at 3.03 and 1.52 g/kg, and K+ at dose of
3.03 g/kg were remarkably decreased compared with control. Sig-
niﬁcant decreases of GLU at doses of 3.03 and 1.52 g/kg, and TP
at dose of 3.03 g/kg were observed, whereas the UREA at dose of
3.03 g/kg was  signiﬁcantly increased compared to control values.
As shown in Table 6, withdrawal of repeated daily oral treat-
ments of BA extract for 14 days caused reductions in the levels of
TP, ALB and TG, signiﬁcantly in male rats at all doses compared
to the control groups. While, in female rats at all doses, signiﬁ-
cant decreases in CHO and ALP were showed. The concentration
of TG was signiﬁcantly decreased in female rats at doses of 3.03
and 1.52 g/kg. Additionally, rats treated with a dose of 3.03 g/kg
exhibited signiﬁcant decreases in GLU in both sexes and remarkable
decreases in CHO in male rats at compared to the control values.
Signiﬁcant increases were observed in the serum levels of UREA
and CREA, in female rats at a dose of 3.03 g/kg compared to control
values.
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Table  3
Hematological parameters of rats after 90 days of treatment with BA.
Parameter Unit Control BA extracts (g/kg)
3.03 1.52 0.76
Male
HGB g/l 160.50 ± 5.10 166.40 ± 6.38a 166.80 ± 7.19a 164.60 ± 3.27
RBC  1012/l 8.56 ± 0.32 10.08 ± 0.23a 8.97 ± 1.18a 8.29 ± 0.32
MCV  fL 54.91 ± 2.11 56.08 ± 1.91a 55.00 ± 2.06 53.18 ± 2.45
MCH  pg 18.76 ± 0.58 19.89 ± 0.72a 19.14 ± 0.86 18.98 ± 0.99
MCHC  g/l 348.20 ± 4.49 356.90 ± 10.72a 354.60 ± 4.65a 348.50 ± 6.04
WBC  109/l 5.87 ± 1.87 8.30 ± 2.47a 5.48 ± 1.02 7.53 ± 1.85
Gran  % 24.66 ± 9.79 16.90 ± 5.34 16.78 ± 5.25 19.32 ± 3.12
Lymph  % 75.50 ± 8.70 74.81 ± 9.15 79.33 ± 6.13 75.33 ± 5.51
MONO  % 5.67 ± 2.54 4.76 ± 5.22 4.40 ± 183 4.16 ± 2.97
PLT  109/l 834.80 ± 332.71 605.00 ± 308.52 1035.70 ± 195.54 954.00 ± 131.15
Female
HGB  g/l 162.40 ± 4.50 160.70 ± 7.30 161.70 ± 5.19 159.00 ± 13.59
RBC  1012/l 8.29 ± 0.30 8.96 ± 1.37 8.41 ± 0.36 8.11 ± 0.80
MCV  fL 54.51 ± 0.71 59.07 ± 1.93a 55.00 ± 1.80 53.99 ± 1.70
MCH  pg 19.58 ± 0.26 20.29 ± 0.49a 19.25 ± 0.38 19.63 ± 0.76
MCHC  g/l 343.80 ± 5.16 363.70 ± 6.62a 359.40 ± 1.78a 350.00 ± 6.02
WBC  109/l 5.80 ± 0.85 6.93 ± 2.04 5.45 ± 0.91 5.99 ± 2.01
Gran  % 15.99 ± 5.13 16.41 ± 3.59 15.55 ± 4.86 14.76 ± 2.65
Lymph  % 78.41 ± 5.32 79.03 ± 16.59 77.49 ± 5.71 75.78 ± 4.24
MONO  % 4.80 ± 2.24 5.39 ± 1.86 4.66 ± 1.88 5.62 ± 3.90
PLT  109/l 672.60 ± 234.58 910.40 ± 521.40 889.70 ± 259.18 773.60 ± 318.33
The values are presented as means ± standard deviation of mean (10 rats/sex/group).
a p < 0.05 compared with the control.
Table 4
Hematological parameters of rats after 14 days of recovery.
Parameter Unit Control BA extracts (g/kg)
3.03 1.52 0.76
Male
HGB g/l 165.80 ± 11.97 167.30 ± 7.29 182.30 ± 3.74 160.10 ± 15.55
RBC  1012/l 8.76 ± 0.39 7.98 ± 2.49 8.73 ± 0.29 8.59 ± 0.62
MCV  fL 54.81 ± 1.70 52.96 ± 1.59 49.23 ± 0.99 53.13 ± 2.56
MCH  pg 18.82 ± 0.90 18.73 ± 1.86 18.09 ± 0.21 18.61 ± 1.14
MCHC  g/l 343.50 ± 16.17 367.40 ± 8.27a 354.70 ± 32.35 350.10 ± 11.25
WBC  109/l 6.69 ± 1.11 10.94 ± 0.86a 6.56 ± 0.90 7.73 ± 1.73
Gran  % 25.42 ± 6.76 22.31 ± 9.88 17.68 ± 7.25 18.91 ± 8.46
Lymph  % 70.55 ± 1.35 69.05 ± 7.52 72.45 ± 3.46 69.74 ± 9.34
MONO  % 7.18 ± 1.43 6.04 ± 2.94 7.28 ± 2.53 6.51 ± 4.69
PLT  109/l 551.20 ± 174.58 690.40 ± 237.47 610.44 ± 100.09 542.00 ± 257.38
Female
HGB  g/l 156.00 ± 19.56 166.90 ± 7.29 163.40 ± 11.24 159.60 ± 2.41
RBC  1012/l 8.44 ± 0.43 8.85 ± 0.45 8.58 ± 0.56 8.15 ± 0.21
MCV  fL 53.53 ± 0.99 56.09 ± 1.36a 54.15 ± 1.82 52.54 ± 2.80
MCH  pg 18.47 ± 2.14 18.89 ± 1.00 19.05 ± 0.51 19.58 ± 0.51
MCHC  g/l 345.00 ± 38.88 359.60 ± 11.24 351.80 ± 4.32 349.40 ± 3.60
WBC  109/l 7.79 ± 2.23 5.76 ± 1.08 7.48 ± 0.98 7.61 ± 1.37
Gran  % 18.44 ± 3.85 16.18 ± 4.58 18.32 ± 4.81 14.91 ± 3.38
Lymph  % 71.68 ± 6.25 77.65 ± 5.25 76.28 ± 7.67 81.81 ± 3.00
MONO  % 6.33 ± 3.95 6.04 ± 2.05 5.95 ± 2.80 6.72 ± 2.59
PLT  109/l 542.60 ± 228.11 683.20 ± 272.71 526.90 ± 191.35 656.70 ± 302.88
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she values are presented as means ± standard deviation of mean (10 rats/sex/group
a p < 0.05 compared with the control.
acropathology and histopathology
In the macroscopic examination, no signiﬁcant difference was
bserved in gross pathology. As shown in Fig. 1, in addition to bleed-
ng, there were no remarkable histological changes observed in the
eart, liver, lungs and kidneys. However, plenty of macrophages
hagocytosed amounts of hemosiderin granules in the spleen was
bserved compared to the organs of the control group. Hemosiderin
ccumulation was showed by arrows in spleen of Figs. 1 and 2.
hese results were not signiﬁcantly changed in the reversibility
tudy (Fig. 2).Discussion
Subchronic studies assess the undesirable effects of continuous
or repeated exposure of plant extracts or compounds over a portion
of the average life span of experimental animals, such as rodents.
They provide information on target organ toxicity and are designed
to identify adverse effect levels (Yuet Ping et al., 2013). In this study,
the subchronic toxicity of a BA extract was evaluated in rats at doses
of 0.76–3.03 g/kg/day for 90 days. Consideration should be given to
an additional satellite group of reversibility, persistence, or delayed
occurrence of systemic toxic effects and recovery from toxic effects
442 Y. Zhang et al. / Revista Brasileira de Farmacognosia 26 (2016) 438–445
Table 5
Biochemical parameters of rats after 90 days of treatment with BA.
Parameter Unit Control BA extracts (g/kg)
3.03 1.52 0.76
Male
Na mmol/l 176.80 ± 10.60 140.10 ± 2.56a 144.70 ± 2.83a 164.50 ± 14.80a
K mmol/l 8.12 ± 1.00 6.98 ± 0.45a 7.77 ± 0.33 7.92 ± 0.54
Cl  mmol/l 137.10 ± 9.43 109.20 ± 1.32a 109.40 ± 2.88a 138.60 ± 12.26
UREA  mmol/l 7.68 ± 1.08 10.31 ± 0.91a 7.01 ± 1.54 7.13 ± 0.83
CREA  mol/l 46.71 ± 13.89 44.66 ± 3.91 47.70 ± 3.79 49.49 ± 3.68
TP  g/l 63.72 ± 3.80 58.41 ± 1.96a 64.51 ± 3.04 64.61 ± 3.63
ALB  g/l 33.98 ± 2.17 33.17 ± 5.26 35.05 ± 2.13 34.86 ± 1.17
ALP  U/l 224.50 ± 3.80 221.60 ± 59.88 208.60 ± 28.07 196.80 ± 32.44
AST  U/l 158.24 ± 24.65 155.06 ± 24.42 146.64 ± 17.38 137.05 ± 28.86
ALT  U/l 58.40 ± 5.83 53.21 ± 7.30 56.71 ± 8.36 58.67 ± 8.00
GLU  mmol/l 5.78 ± 0.78 4.47 ± 0.56a 4.74 ± 0.66a 5.51 ± 0.50
CHO  mmol/l 1.55 ± 0.24 1.58 ± 0.23 1.65 ± 0.20 1.66 ± 0.22
TG  mmol/l 0.54 ± 0.15 0.59 ± 0.0.08 0.52 ± 0.16 0.56 ± 0.11
Female
Na  mmol/l 172.20 ± 12.78 140.60 ± 5.60a 143.70 ± 1.83a 174.60 ± 13.78
K  mmol/l 8.11 ± 0.45 6.48 ± 1.20a 7.42 ± 0.38a 7.42 ± 0.63a
Cl mmol/l 142.90 ± 7.25 105.90 ± 5.53a 111.30 ± 2.06a 138.00 ± 12.84
UREA  mmol/l 7.61 ± 1.48 10.28 ± 1.40a 10.42 ± 1.91a 8.60 ± 2.06
CREA  mol/l 45.13 ± 6.12 45.05 ± 5.78 48.91 ± 4.75 45.96 ± 11.08
TP  g/l 75.36 ± 6.22 64.75 ± 5.94a 69.02 ± 4.65a 73.07 ± 4.05
ALB  g/l 39.77 ± 3.11 35.50 ± 4.52a 40.39 ± 2.16 37.48 ± 2.89
ALP  U/l 195.60 ± 31.74 183.20 ± 51.35 179.60 ± 21.73 181.90 ± 19.04
AST  U/l 157.36 ± 59.75 147.09 ± 39.30 171.40 ± 39.58 139.63 ± 38.42
ALT  U/l 57.28 ± 10.41 58.47 ± 9.23 53.03 ± 21.62 61.34 ± 37.67
GLU  mmol/l 6.45 ± 0.47 3.90 ± 1.23a 4.88 ± 0.64a 5.88 ± 0.64
CHO  mmol/l 2.28 ± 0.47 1.62 ± 0.42 2.14 ± 0.47 2.28 ± 0.65
TG  mmol/l 1.46 ± 0.29 0.74 ± 0.29a 0.92 ± 0.23a 1.56 ± 0.43
The values are presented as means ± standard deviation of mean (10 rats/sex/group).
a p < 0.05 compared with the control.
Table 6
Biochemical parameters of rats after 14 days of recovery.
Parameter Unit Control BA extracts (g/kg)
3.03 1.52 0.76
Male
Na mmol/l 141.00 ± 1.05 142.50 ± 1.51 142.20 ± 2.25 142.30 ± 1.49
K  mmol/l 6.71 ± 0.32 7.15 ± 0.34 6.98 ± 0.64 6.96 ± 0.38
Cl  mmol/l 105.80 ± 1.69 106.70 ± 1.49 107.20 ± 0.79 106.60 ± 1.78
UREA  mmol/l 8.08 ± 1.15 7.18 ± 1.14 7.73 ± 0.72 7.10 ± 0.49
CREA  mol/l 44.39 ± 1.31 47.28 ± 16.22 46.44 ± 4.40 44.16 ± 9.03
TP  g/l 75.52 ± 4.25 70.98 ± 1.70a 70.11 ± 4.54a 69.68 ± 1.71a
ALB g/l 45.57 ± 2.04 41.65 ± 1.36a 42.48 ± 2.17a 41.42 ± 0.81a
ALP U/l 211.30 ± 14.61 156.50 ± 55.54 183.20 ± 26.87 261.10 ± 48.56
AST  U/l 175.51 ± 18.20 157.47 ± 25.83 180.22 ± 22.71 195.78 ± 77.08
ALT  U/l 96.93 ± 8.98 92.51 ± 8.36 96.51 ± 10.73 97.78 ± 13.66
GLU  mmol/l 7.76 ± 0.57 7.42 ± 2.72 8.18 ± 0.74 8.19 ± 1.30
CHO  mmol/l 2.71 ± 0.68 1.77 ± 0.67a 2.00 ± 0.48 2.48 ± 0.45
TG  mmol/l 1.02 ± 0.17 0.53 ± 0.19a 0.81 ± 0.13a 0.79 ± 0.15a
Female
Na mmol/l 143.40 ± 2.07 142.20 ± 1.48 142.70 ± 1.70 142.10 ± 2.02
K  mmol/l 6.56 ± 0.16 7.03 ± 0.74 6.19 ± 0.56 6.96 ± 0.46
Cl  mmol/l 106.30 ± 1.77 107.30 ± 2.75 108.00 ± 1.32 106.90 ± 2.42
UREA  mmol/l 6.83 ± 0.56 9.29 ± 0.53a 7.79 ± 1.72 7.86 ± 1.46
CREA  mol/l 39.92 ± 1.07 57.14 ± 9.07a 46.57 ± 8.77 45.04 ± 18.87
TP  g/l 74.83 ± 2.81 74.94 ± 3.52 77.65 ± 2.45 76.94 ± 4.59
ALB  g/l 45.10 ± 2.65 45.44 ± 0.98 46.55 ± 1.22 46.23 ± 1.99
ALP  U/l 230.70 ± 10.13 78.40 ± 19.88a 168.20 ± 56.23a 186.70 ± 26.97a
AST U/l 157.93 ± 25.66 172.66 ± 52.78 192.96 ± 35.17 155.92 ± 22.19
ALT  U/l 77.03 ± 4.74 68.37 ± 12.70 88.60 ± 17.11 88.98 ± 18.75
GLU  mmol/l 8.46 ± 0.63 6.14 ± 0.80a 8.44 ± 0.77 8.05 ± 1.34
CHO  mmol/l 2.61 ± 0.14 2.06 ± 0.10a 2.27 ± 0.15a 2.19 ± 0.28a
TG mmol/l 1.46 ± 0.29 0.74 ± 0.29a 0.92 ± 0.23a 1.56 ± 0.43
The values are presented as means ± standard deviation of mean (10 rats/sex/group).
a p < 0.05 compared with the control.
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cig. 1. Effects of 3.03 g/kg of BA extract on the microstructures of various rat organ
nd  (p): spleen; (g), (h), (q) and (r): lung; (i), (j), (s) and (t): kidney.
or at least 14 days after treatment (Yuet Ping et al., 2013). The
atellite group in this study was orally administered a BA extract
t a daily dose of 0.76–3.03 g/kg/day for 90 days with no further
reatment for the following 14 days before the termination of the
tudy.
In this study, no signiﬁcant changes in the weights of the heart,
pleen, lungs and kidneys were observed, suggesting that admin-
stration of BA extracts at subchronic oral doses had no effect
n normal growth. The usefulness of weighing organs in toxic-
ty studies includes their sensitivity to toxicity, enzyme induction,
hysiologic perturbations, and acute injury. It is frequently a tar-
et organ of toxicity and correlates well with histopathological
hanges (Michael et al., 2007). The relative organ weights have been
bserved in toxicity studies to be a relatively sensitive indicator
or particular organs and therefore deﬁne toxicity as signiﬁcant
hanges observed in those particular organs (Kluwe, 1981). The 90 days (HE 400×). (a), (b), (k) and (l): heart; (c), (d), (m) and (n): liver; (e), (f), (o)
results of this study revealed that the essential organs, such as
heart, liver, spleen, kidneys, and lungs, were not adversely affected
and showed no clinical signs of toxicity throughout the treatment.
Because there was no reduction in relative organ weights of the
treated animals at any of the tested doses, we concluded that the
BA extract has no obvious toxicity in the analyzed organs.
Evaluation of hematological parameters can be used to deter-
mine the extent of the deleterious effect of extracts on an animal’s
blood. This approach can also be used to explain blood relevant
functions of a plant extract or its products (Yakubu et al., 2007).
A hemogram was conducted for all BA extract treated and con-
trol groups and the results show signiﬁcant increases in Hb, RBC,
MCV, MCH  and MCHC at any dose. The signiﬁcant effect of the
extract indicates that the BA extract affects the erythropoiesis, mor-
phology, or osmotic fragility of the RBC. Leukocytes are the ﬁrst
line of cellular defense that responds to infectious agents, tissue
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fig. 2. Effects of 3.03 g/kg of BA extract on the microstructures of various rat organ
e),  (f), (o) and (p): spleen; (g), (h), (q) and (r): lung; (i), (j), (s) and (t): kidney.
njury, toxic effect or inﬂammatory processes. Furthermore, signif-
cant change was observed in the WBC  in the BA group at a dose of
.03 g/kg, which conﬁrmed tissue damage or toxicity.
The serum hematology and clinical biochemistry analyses were
erformed to evaluate the possible alterations in hepatic and renal
unctions inﬂuenced by the extracts. Liver and kidney function
nalysis is very important in the toxicity evaluation of drugs and
lant extracts as they are both necessary for the survival of an
rganism (Yuet Ping et al., 2013). Liver is the major organ involved
n drug metabolism and elimination. High levels of ALT, AST, and
LP are reported in liver diseases or hepatotoxicity (Brautbar and
illiams, 2002). Production of TP is another typical function of
iver. A decrease in TP and ALB is a sign of the reduced synthetic
unction of the liver or might be due to impaired hepatocellular
unction (Yuet Ping et al., 2013). There were no signiﬁcant increases14 days of recovery (HE 400×). (a), (b), (k) and (l): heart; (c), (d), (m)  and (n): liver;
in serum ALT, AST and ALP values in either male or female rats at all
doses, but other hepatic function parameters, such as TP and ALB,
were signiﬁcantly decreased at all of the doses tested. The changes
of TP and ALB were irreversible with the extract withdrawal for
14 days in male rats at all doses. Thus, the signiﬁcant changes in
serum concentrations of TP and ALB conﬁrmed that the BA extract
damaged the hepatocellular or secretory functions of the liver. At
the same time, the toxic effects in liver appeared delayed in male
rats at all doses. Liver as an important organ in the synthesis of
CHO and TG, liver injury may  hinder the normal synthesis of CHO
and TG. In our results, BA caused a signiﬁcant decrease in CHO and
TG. These results indicate that BA affects the live function and lipid
metabolism imbalance.
The function of kidney has important inﬂuence on drug
metabolism. Many medicines can cause kidney injury (Gobe et al.,
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015). Renal dysfunction can be assessed by concurrent measure-
ents of electrolytes, urea and creatinine (Akindele et al., 2014).
hanges in Na+, K+ and Cl− levels in some BA extract groups showed
igniﬁcant differences indicating an abnormal renal function. This
amage was further conﬁrmed by signiﬁcant increases in urea and
reatinine levels in all groups.
Although clinical biochemistry analysis showed liver and
idney damage, none of these organs from the BA extract
reated rats showed any signiﬁcant alteration in cell structure
r any unfavorable effects compared to the control group when
iewed under the light microscope. Hemosiderin depositions were
bserved in the spleens after BA extract treatment. An increase
f hemoglobin indicated that the BA extract damaged the spleen
unction.
In general, the subchronic toxicity of baked A. ﬂavum was
educed enormously by the method described in “Preparation of
thanol root extract of baked Aconitum ﬂavum” section. In our
esearch, no deaths or serious clinical signs were found. At the
ame time, the morphological and histopathological changes were
ot observed in the main organs except for spleen. The changes
n hematological parameters and clinical biochemistry analyses
howed that the damage to metabolic organs (liver and kidneys)
as slight. It is worth noting that the damage to the spleen may  be
elated to an inhibitory effect on immune function. Thus, regarding
amage to the liver, kidney and spleen functions, caution should be
xercised when using the BA extract for long term therapy. How-
ver, these toxicities may  not be overly serious because BA toxicity
s signiﬁcantly less than A. ﬂavum.  The ancient Chinese said that
oxicity is the proﬁle of a drug; therefore, we believe that BA will
mprove the patient’s life if BA is applied reasonably.
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